J.P. Morgan Raises Merck Target Price to $150

J.P. Morgan analyst Chris Schott has maintained his buy rating on Merck & Co (MRK.US) and increased its target price to $150.

This decision was made after reviewing the company's performance, and Schott's success rate as an analyst is noted at 57.3% with a total average return of 5.7% over the past year.

The note also mentions that TipRanks provides analysis data from financial analysts and calculates their Average Returns and Success Rates, but emphasizes that this information is not an investment recommendation.